STOCKHOLDERS' EQUITY (Details) - USD ($)
|
|
|
|
1 Months Ended |
3 Months Ended |
9 Months Ended |
12 Months Ended |
|
|
Aug. 14, 2020 |
Jun. 03, 2020 |
May 06, 2020 |
Jan. 31, 2020 |
Aug. 30, 2019 |
Sep. 30, 2020 |
Sep. 30, 2019 |
Sep. 30, 2020 |
Dec. 31, 2018 |
Dec. 31, 2019 |
Sep. 28, 2018 |
STOCKHOLDERS' EQUITY (Details) [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Preferred stock, authorized |
|
|
|
|
|
5,000,000
|
|
5,000,000
|
|
10,000,000
|
|
Preferred stock, par value (in Dollars per share) |
|
|
|
|
|
$ 0.0001
|
|
$ 0.0001
|
|
$ 0.0001
|
|
Preferred stock, shares Issued |
|
|
|
|
|
|
|
|
|
|
|
Preferred stock, shares outstanding |
|
|
|
|
|
|
|
|
|
|
|
Certificate of designation series A preferred stock |
5,000,000
|
|
|
|
|
|
|
|
|
|
|
Percentage purchase price |
25.00%
|
|
|
|
|
|
|
|
|
|
|
Effective interest rate |
25.00%
|
|
|
|
|
|
|
|
|
|
|
Stockholder debt term |
1 year
|
|
|
|
|
|
|
|
|
|
|
Common stock, authorized |
|
|
|
|
|
350,000,000
|
|
350,000,000
|
|
350,000,000
|
|
Common stock, par value (in Dollars per share) |
|
|
|
|
|
$ 0.0001
|
|
$ 0.0001
|
|
$ 0.0001
|
|
Common stock, outstanding |
|
|
|
|
|
59,388,085
|
|
59,388,085
|
|
59,268,085
|
|
Common stock, issued |
|
|
|
|
|
59,388,085
|
|
59,388,085
|
|
59,268,085
|
|
Number of shares to purchase by stock option |
|
|
|
19,625
|
24,428,681
|
|
|
|
|
|
|
Amount of shares to purchase by stock option (in Dollars) |
|
|
|
$ 15,479
|
|
$ 4,217,969
|
$ 5,268,333
|
|
|
|
|
Restricted stock purchase |
|
3,000,000
|
|
|
|
|
|
|
|
|
|
2018 Equity Incentive Plan [Member] |
|
|
|
|
|
|
|
|
|
|
|
STOCKHOLDERS' EQUITY (Details) [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Common stock reserved for issuance |
|
|
|
|
|
10,000,000
|
|
10,000,000
|
|
|
|
Preferred Stock [Member] |
|
|
|
|
|
|
|
|
|
|
|
STOCKHOLDERS' EQUITY (Details) [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Preferred stock, authorized |
|
|
|
|
|
10,000,000
|
|
10,000,000
|
|
|
|
Preferred stock, par value (in Dollars per share) |
|
|
|
|
|
$ 0.0001
|
|
$ 0.0001
|
|
|
|
Preferred stock, shares Issued |
|
|
|
|
|
5,000,000
|
|
5,000,000
|
|
|
|
Preferred stock, shares outstanding |
|
|
|
|
|
5,000,000
|
|
5,000,000
|
|
|
|
Amount of shares to purchase by stock option (in Dollars) |
|
|
|
|
|
$ 222
|
|
|
|
|
|
Common Stock [Member] |
|
|
|
|
|
|
|
|
|
|
|
STOCKHOLDERS' EQUITY (Details) [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Common stock, authorized |
|
|
|
|
|
350,000,000
|
|
350,000,000
|
|
|
|
Common stock, par value (in Dollars per share) |
|
|
|
|
|
$ 0.0001
|
|
$ 0.0001
|
|
|
$ 0.0001
|
Common stock, outstanding |
|
|
|
|
|
59,388,085
|
|
59,388,085
|
|
|
|
Common stock, issued |
|
|
|
|
|
59,388,085
|
|
59,388,085
|
|
|
|
Amount of shares to purchase by stock option (in Dollars) |
|
|
|
|
|
|
$ 243
|
|
|
|
|
Warrants [Member] |
|
|
|
|
|
|
|
|
|
|
|
STOCKHOLDERS' EQUITY (Details) [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Vesting period |
|
|
5 years
|
|
|
|
|
|
|
|
|
Stock compensation expense (in Dollars) |
|
|
|
|
|
0
|
|
$ 83,654
|
|
|
|
Warrants outstanding |
|
|
|
|
|
|
|
5,639,167
|
|
|
|
Weighted-average contractual remaining life |
|
|
|
|
|
|
|
2 years 4 months 24 days
|
|
|
|
Exercise prices decrease (in Dollars per share) |
|
|
|
|
|
|
|
$ 0.01
|
|
|
|
Exercise prices increase (in Dollars per share) |
|
|
|
|
|
|
|
3.25
|
|
|
|
Weighted average exercise price (in Dollars per share) |
|
|
|
|
|
|
|
$ 3.05
|
|
|
|
Stock Options [Member] |
|
|
|
|
|
|
|
|
|
|
|
STOCKHOLDERS' EQUITY (Details) [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Stock compensation expense (in Dollars) |
|
|
|
|
|
$ 81,174
|
|
$ 833,959
|
|
|
|
Stock options to purchase |
|
|
1,499,000
|
|
|
1,499,000
|
|
1,499,000
|
|
|
|
Stock options exercise price (in Dollars per share) |
|
|
$ 2.13
|
|
|
|
|
|
|
|
|
Weighted-average contractual remaining life |
|
|
|
|
|
|
|
9 years 7 months 6 days
|
|
|
|
Stock option exercise price, decrease (in Dollars per share) |
|
|
|
|
|
|
|
$ 2.13
|
|
|
|
Unrecognized compensation expense (in Dollars) |
|
|
|
|
|
$ 301,216
|
|
$ 301,216
|
|
|
|
Expected weighted average vesting period |
|
|
|
|
|
|
|
1 year 7 months 6 days
|
|
|
|
Securities Purchase Agreement [Member] |
|
|
|
|
|
|
|
|
|
|
|
STOCKHOLDERS' EQUITY (Details) [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Agreement, description |
the Company entered into securities purchase agreements (the “2020 Purchase Agreements”) with certain purchasers (the
“2020 Investors”), which provided for the sale of an aggregate of $4,435,000 and the exchange for debt of $265,779
of the Company’s Series A Convertible Preferred Stock (the “Series A Preferred”) at a purchase price of $2.00
per share (the “Purchase Price”) (the “Offering”). On August 14, 2020 and August 27, 2020, pursuant to
the 2020 Purchase Agreements, the Company issued an aggregate of 2,350,390 shares of Series A Preferred to the Investors (collectively
the “2020 Closing”). In connection with the 2020 Closing, Eric Brock, the Company’s Chief Executive Officer purchased
157,500 shares of Series A Preferred. The aggregate gross proceeds to the Company from the 2020 Closing was $4,700,779. After payment
of offering expenses, the net proceeds to the Company from the 2020 Closing was $4,483,749.
|
|
|
|
|
|
|
|
|
|
|
Issue Price One [Member] | Warrants [Member] |
|
|
|
|
|
|
|
|
|
|
|
STOCKHOLDERS' EQUITY (Details) [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Warrants to purchase shares |
|
|
143,750
|
|
|
|
|
|
|
|
|
Warrants exercise price (in Dollars per share) |
|
|
$ 2.50
|
|
|
|
|
|
|
|
|
Issue Price Two [Member] | Warrants [Member] |
|
|
|
|
|
|
|
|
|
|
|
STOCKHOLDERS' EQUITY (Details) [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Warrants to purchase shares |
|
|
29,375
|
|
|
|
|
|
|
|
|
Warrants exercise price (in Dollars per share) |
|
|
$ 2.13
|
|
|
|
|
|
|
|
|
Issue Price Three [Member] | Stock Options [Member] |
|
|
|
|
|
|
|
|
|
|
|
STOCKHOLDERS' EQUITY (Details) [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Number of shares to purchase by stock option |
|
|
694,625
|
|
|
|
|
|
|
|
|
Issue Price Three [Member] | Warrants [Member] |
|
|
|
|
|
|
|
|
|
|
|
STOCKHOLDERS' EQUITY (Details) [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Warrants to purchase shares |
|
|
694,625
|
|
|
|
|
|
|
|
|
Warrants exercise price (in Dollars per share) |
|
|
$ 2.50
|
|
|
|
|
|
|
|
|
Restricted Stock Units (RSUs) [Member] |
|
|
|
|
|
|
|
|
|
|
|
STOCKHOLDERS' EQUITY (Details) [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Vesting period |
|
|
|
|
|
|
|
2 years
|
|
|
|
Stock compensation expense (in Dollars) |
|
|
|
|
|
1,050,000
|
|
$ 2,100,000
|
|
|
|
Unrecognized compensation expense (in Dollars) |
|
|
|
|
|
$ 6,300,000
|
|
$ 6,300,000
|
|
|
|
Restricted stock purchase |
|
|
|
|
|
|
|
|
378,478
|
|
|
Shares options issued non-vested |
|
|
|
|
|
2,250,000
|
|
2,250,000
|
|
|
|
Weighted average grant-date fair value of exercise price (in Dollars per share) |
|
|
|
|
|
|
|
$ 2.80
|
|
|
|
Weighted-average contractual remaining life |
|
|
|
|
|
|
|
1 year 6 months
|
|
|
|
Weighted average grant-date fair value (in Dollars per share) |
|
|
|
|
|
|
|
$ 0.22
|
|
|
|
Vesting period |
|
|
|
|
|
|
|
2 years
|
|
|
|
Consultant [Member] | Restricted Stock Units (RSUs) [Member] |
|
|
|
|
|
|
|
|
|
|
|
STOCKHOLDERS' EQUITY (Details) [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
Stock compensation expense (in Dollars) |
|
|
|
|
|
$ 10,117
|
|
$ 30,357
|
|
|
|